Skip to main content

NPF Endorsed Features

Lauren Mateja, Managing Editor
New and emerging therapies such as biologics continue to improve quality of life and outcomes for patients with psoriasis. Biologics that block IL-23 functions present a unique opportunity to provide long-term, effective treatment.
Lauren Mateja, Managing Editor
It is hypothesized that psoriatic arthritis is too often underdiagnosed, and therefore undertreated, in dermatology. In an interview with The Dermatologist, Drs Joseph F. Merola and Alice B. Gottlieb shared their insights as dual dermatologist-rheumatologists on screening for psoriatic arthritis in the patient with psoriasis.
Lauren Mateja, Managing Editor
Psoriasis can affect patients at all walks of life, from children to the elderly. Adolescents, however, require special considerations, from psychosocial conditions to therapy options, for the short- and long-term management of psoriasis.
Melissa Weiss, Associate Editor, Lauren Mateja, Managing Editor
Several breakthrough studies and prominent clinical guidelines related to psoriasis were published in 2019. Review some of the most impactful psoriasis content published this year.
Melissa Weiss, Associate Editor
The American Academy of Dermatology and National Psoriasis Foundation released new guidelines on the use of phototherapy for the treatment of psoriasis. Joel Gelfand, MD, MSCE, discussed the updated guidelines with The Dermatologist.
Peter Sonnenreich; Bassem Wolley; and Katherine Moody, Contributing Writers
Certain comorbidities—particularly congestive heart failure, tuberculosis, and HIV infection—can affect the type of psoriasis treatment physicians recommend to their patients.
Melissa Weiss, Associate Editor
Access restrictions to therapies among patients with rheumatoid arthritis and psoriatic arthritis can significantly impact treatment effectiveness and adherence. Natalie Boytsov, PhD, discussed the implications of these restrictions with The Dermatologist.
Melissa Weiss, Associate Editor
Dermatologists have another weapon in their arsenal to prescribe for patients with mild plaque psoriasis.
Peter Sonnenreich; Bassem Wolley; and Linda Geisler, Contributing Writers
The palmoplantar form of psoriasis affects roughly a quarter of those with moderate to severe symptoms and presents unique treatment challenges.
Steve Bieler, National Psoriasis Foundation Staff Writer
The National Psoriasis Foundation is collaborating in a real-world trial evaluating the safety and effectiveness of home vs office phototherapy with the goals of providing important data for this therapeutic option and supporting patient-centered research. Dermatology practices can volunteer to act as clinical sites.
Back to Top